The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models.
Ontology highlight
SUBMITTER: Masanas M
PROVIDER: S-EPMC8516339 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA